Clinical Research Site for Gastroenterology, IBD & Hepatology
WIP Warsaw IBD Point is a dedicated clinical research site in Warsaw operating alongside a multi-specialty outpatient clinic and endoscopy unit. The site conducts Phase I-IV studies in adult and paediatric populations and has operated under ICH-GCP standards since 2000.
Integrated Clinical Research in Warsaw
WIP Warsaw IBD Point is a dedicated clinical research site specialising in inflammatory bowel disease and gastroenterology. Research activity is integrated with a multi-specialty outpatient clinic and an endoscopy unit.
Patients can be followed in routine clinical care at the same location, supporting efficient identification of potentially eligible participants and a streamlined screening pathway for interventional studies.
The site works predominantly with global pharmaceutical sponsors, specialist biotechnology companies and international CROs.
Medical Network Sp. z o.o.
WIP Warsaw IBD Point operates in Warsaw, Poland and has conducted clinical research activities since 2000.
- Phase I-IV clinical studies
- Adult and paediatric populations
- ICH-GCP research environment
- On-site outpatient specialist care
- On-site endoscopy capabilities
- English and Polish working languages
Core Therapeutic Areas
The site's strongest therapeutic focus is gastroenterology and inflammatory bowel disease, supported by adjacent specialist areas relevant to complex clinical research protocols.
Experienced Academic Investigators
The research team is led by nationally recognised academic gastroenterologists with extensive publication records and active involvement in professional and international expert groups.
The investigator base has expanded since 2025, strengthening site continuity and reducing dependency on a single investigator.
Selected publications of the investigator team can be provided on request.
Research Team Structure
- Principal Investigators: 9
- Sub-investigators: 14
- Study coordinators and research nurses: 12 FTE
- Regulatory, pharmacy and data staff: 4 FTE
- Dedicated research coordination
- Blinded and unblinded workflows can be supported where required
Patient Access Embedded in Routine Care
The research site operates alongside routine gastroenterology and paediatric care, supporting identification of potentially eligible patients and continuity between clinical care and research.
Routine Follow-up
An established population of IBD patients is followed through routine specialist care at the same Warsaw location.
Active IBD patient base under routine follow-up: 800.
Referral Network
The site works with a network of gastroenterologists and paediatricians supporting referral and patient identification.
Referral network: 20 physicians.
Recruitment Experience
The team has historical experience recruiting patients across multiple clinical research programmes and therapeutic indications.
Historical enrolment: 300 patients across 50 studies.
Recruitment target achievement: 95% of studies met or exceeded their recruitment target.
Clinical Research Infrastructure
WIP combines clinical research rooms, specialist diagnostics, pharmacy and sample-handling infrastructure within the site and through established cooperating services.
Structured Site Operations
The site supports EDC, electronic investigator site file workflows and remote monitoring. Research documentation and source access are organised for sponsor and CRO monitoring requirements.
- EDC workflows supported
- eISF workflows supported
- Remote monitoring supported
- Dedicated monitoring workspace
- English and Polish working languages
Operational Turnaround
Benchmark figures below are hidden until confirmed for publication.
Current site turnaround benchmarks are available during feasibility assessment.
Compliance Built Into Site Operations
The site maintains an ICH-GCP compliant SOP framework and ongoing GCP training for research personnel.
- ICH-GCP compliant SOP set
- Ongoing GCP training for research staff
- Compliance with Regulation (EU) 536/2014 and applicable Polish clinical trial law
- Insurance and indemnity arrangements for active studies
- 45 sponsor audits and 5 regulatory inspections completed with no critical findings
Experience With Global Sponsors and CROs
WIP Warsaw IBD Point has delivered clinical research projects for global pharmaceutical organisations, specialist biotechnology companies and international CROs.
Sponsor names can be provided under appropriate confidentiality arrangements.
Selected publications from the investigator team are also available on request.
Long-term Research Cooperation
The site is structured to support repeat sponsor collaboration, continuity across protocols and long-term relationships with research partners.
- 10 sponsor groups
- 90% repeat sponsor business
- Longest continuous sponsor relationship: 20 years
Discuss a Study With Our Research Team
Contact WIP Warsaw IBD Point regarding feasibility, investigator capabilities, recruitment potential or potential cooperation on a clinical research project in Poland.
Płowiecka 103
04-501 Warsaw, Poland